Acute antibody-mediated rejection after lung transplantation.

The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant (2011) 1.98

Pathologic findings in lung allografts with anti-HLA antibodies. J Heart Lung Transplant (2013) 0.93

Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant (2013) 0.93

Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients. J Heart Lung Transplant (2010) 0.88

Antibody-mediated rejection of a unilateral donor lung in bilateral living-donor lobar lung transplantation: report of a case. Surg Today (2012) 0.82

Antibody-Mediated Lung Transplant Rejection. Curr Respir Care Rep (2012) 0.78

Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation. World J Gastroenterol (2015) 0.76

Unilateral humoral rejection after reoperative single-lung transplant. Ann Thorac Surg (2013) 0.76

Antibody-mediated Rejection in Lung Transplantation. Curr Transplant Rep (2015) 0.75

Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction. Semin Immunol (2011) 0.75

Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med (2008) 4.70

Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med (2006) 2.69

Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest (2006) 2.33

Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg (2002) 2.19

Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2010) 2.06

Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007. J Heart Lung Transplant (2007) 2.03

De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol (2008) 1.95

Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med (2004) 1.95

Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol (2011) 1.93

Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2002) 1.86

Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg (2003) 1.80

Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol (2009) 1.74

Cutting edge: Acute lung allograft rejection is independent of secondary lymphoid organs. J Immunol (2009) 1.64

Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J Immunol (2005) 1.61

Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report--2006. J Heart Lung Transplant (2006) 1.58

Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol (2004) 1.56

Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation (2007) 1.54

Potential for detrimental hyperinflation after lung transplantation with application of negative pleural pressure to undersized lung grafts. J Thorac Cardiovasc Surg (2003) 1.54

Sternoclavicular joint infection: a comparison of two surgical approaches. Ann Thorac Surg (2011) 1.52

Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg (2005) 1.52

Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report--2007. J Heart Lung Transplant (2007) 1.51

A prospective evaluation of lung volume reduction surgery in 200 consecutive patients. Chest (2003) 1.51

Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg (2008) 1.50

Benefits of resection for metachronous lung cancer. J Thorac Cardiovasc Surg (2004) 1.50

Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol (2003) 1.50

Prevalence of benign disease in patients undergoing resection for suspected lung cancer. Ann Thorac Surg (2006) 1.46

Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol (2003) 1.46

The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation (2005) 1.46

Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest (2013) 1.42

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant (2010) 1.41

Nonoperative management of large tracheal injuries. J Thorac Cardiovasc Surg (2008) 1.40

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes. J Heart Lung Transplant (2005) 1.39

Results of lung volume reduction surgery in patients meeting a national emphysema treatment trial high-risk criterion. J Thorac Cardiovasc Surg (2004) 1.39

Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant (2011) 1.37

The registry of the international society for heart and lung transplantation: nineteenth official report-2002. J Heart Lung Transplant (2002) 1.36

Outcomes after resection of giant emphysematous bullae. Ann Thorac Surg (2004) 1.33

Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants. Am J Respir Cell Mol Biol (2007) 1.33

Bronchial fenestration improves expiratory flow in emphysematous human lungs. Ann Thorac Surg (2003) 1.32

Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thorac Surg (2010) 1.32

Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling. J Immunol (2006) 1.31

Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J Infect Dis (2005) 1.31

Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant (2005) 1.31

Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology. Nat Protoc (2009) 1.30

The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report--2003. J Heart Lung Transplant (2003) 1.29

Lymph node evaluation in video-assisted thoracoscopic lobectomy versus lobectomy by thoracotomy. Ann Thorac Surg (2010) 1.29

Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant (2005) 1.27

Effects of CT section thickness and reconstruction kernel on emphysema quantification relationship to the magnitude of the CT emphysema index. Acad Radiol (2010) 1.26

Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg (2008) 1.24

Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005. J Heart Lung Transplant (2005) 1.24

Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. J Thorac Cardiovasc Surg (2006) 1.24

Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg (2002) 1.21

A simple, reproducible, and inexpensive technique in the preparation of explanted emphysematous lungs for ex vivo studies. J Thorac Cardiovasc Surg (2005) 1.16

Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center. J Thorac Cardiovasc Surg (2010) 1.15

The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report--2004. J Heart Lung Transplant (2004) 1.14

CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants. J Immunol (2008) 1.14

Outcomes and perception of lung surgery with implementation of a patient video education module: a prospective cohort study. J Am Coll Surg (2012) 1.13

Use of an apical heart suction device for exposure in lung transplantation. Ann Thorac Surg (2006) 1.13

Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival. Ann Thorac Surg (2011) 1.12

Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant (2004) 1.10

Oxidative damage to nucleic acids in severe emphysema. Chest (2008) 1.10

Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database. Ann Thorac Surg (2013) 1.10

Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant (2004) 1.09

Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761. J Thorac Cardiovasc Surg (2002) 1.08

Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer. J Thorac Cardiovasc Surg (2005) 1.06

Bronchiolitis obliterans syndrome: pathogenesis and management. Semin Thorac Cardiovasc Surg (2004) 1.05

Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer (2005) 1.05

National patterns of care and outcomes after combined modality therapy for stage IIIA non-small-cell lung cancer. J Thorac Oncol (2014) 1.05

Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric lung and heart/lung transplantation report--2007. J Heart Lung Transplant (2007) 1.04

Comparison of open subxiphoid pericardial drainage with percutaneous catheter drainage for symptomatic pericardial effusion. Ann Thorac Surg (2003) 1.03

Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg (2004) 1.03

A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. J Thorac Cardiovasc Surg (2011) 1.03

Feasibility and safety of the airway bypass procedure for patients with emphysema. J Thorac Cardiovasc Surg (2003) 1.02

Macrophage chitinase 1 stratifies chronic obstructive lung disease. Am J Respir Cell Mol Biol (2009) 1.02

Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. Transplantation (2002) 1.02

Pneumonia in the solid organ transplant patient. Clin Chest Med (2005) 1.01

Cigarette smoke induces nucleic-acid oxidation in lung fibroblasts. Am J Respir Cell Mol Biol (2009) 1.01

Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells. Transplantation (2002) 1.00

IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. Am J Respir Crit Care Med (2006) 1.00

Treatment of malignant pleural effusion: a cost-effectiveness analysis. Ann Thorac Surg (2012) 0.99

Respiratory virus-induced dysregulation of T-regulatory cells leads to chronic rejection. Ann Thorac Surg (2010) 0.98

Reliability for grading acute rejection and airway inflammation after lung transplantation. J Heart Lung Transplant (2005) 0.98